| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/06/2011 | CN102000299A Medicine for treating hyperlipidaemia |
| 04/06/2011 | CN102000266A Medicament for treating cardiovascular and cerebrovascular diseases and brain paralysis and preparation method thereof |
| 04/06/2011 | CN102000264A Composition for treating climacteric syndrome as well as preparation method and detection method thereof |
| 04/06/2011 | CN102000256A Traditional Chinese medicine composition for treating hypoglycemia |
| 04/06/2011 | CN102000244A Traditional Chinese medicine preparation for treating diabetes mellitus |
| 04/06/2011 | CN102000242A Medicine for treating chronic disease associated malnutrition and application thereof |
| 04/06/2011 | CN102000205A Health protection tea for replenishing trace elements of human body |
| 04/06/2011 | CN102000185A Formula of Chinese medicament with weight-losing effect |
| 04/06/2011 | CN102000170A Weight-reducing composition and preparation method thereof |
| 04/06/2011 | CN102000169A Hairyvein agrimony extract and application thereof in preparation of medicament for treating diabetes mellitus |
| 04/06/2011 | CN102000168A Medicament for reducing blood sugar |
| 04/06/2011 | CN102000163A Bowel-relaxing weight reducing tea |
| 04/06/2011 | CN102000157A Medicinal liquor with treatment and health-care functions |
| 04/06/2011 | CN102000138A Method for purifying effective ingredients of cicer ariethnum L. bean sprouts |
| 04/06/2011 | CN102000126A Ginkgo flavone tablet and preparation method thereof |
| 04/06/2011 | CN102000124A Ginkgo biloba extract oral liquid and preparation method thereof |
| 04/06/2011 | CN102000123A Ginkgo flavone capsule and preparation method thereof |
| 04/06/2011 | CN102000075A Novel pharmaceutical composite containing amlodipine and atorvastatin calcium anhydride |
| 04/06/2011 | CN102000064A Medicinal application of flavanonol lignan in preparation glycosidase inhibitors |
| 04/06/2011 | CN102000063A Application of E ring benzyloxy substituted silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000062A Application of E ring bromine substituted silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000061A Medicinal application of nitrobenzoyl silybin to preparation of glycosidase inhibitor |
| 04/06/2011 | CN102000060A Application of E ring iodine substituted silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000059A Medicinal application of querecetin dipolymer flavonoids to preparation of glycosidase enzyme inhibitors |
| 04/06/2011 | CN102000058A Application of B/E ring changed silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000057A Application of 4-cinnamoyl chloride substituted silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000056A Application of B ring methoxy substituted silybin to preparing glycosidase inhibitors |
| 04/06/2011 | CN102000054A Flavone analog, preparation and application thereof as anti-diabetic medicament |
| 04/06/2011 | CN102000035A Zoledronic acid composition for injection and preparation method thereof |
| 04/06/2011 | CN101999663A Application of traditional Chinese medicine combination in preparing healthcare food and medicine capable of releasing physical fatigue |
| 04/06/2011 | CN101999482A Diet tea formula |
| 04/06/2011 | CN101780251B Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof |
| 04/06/2011 | CN101732513B Shoumingshan capsules for treating hyperlipidemia and method for preparing same |
| 04/06/2011 | CN101684103B Compound with 1,2,4-triazole structure and preparation method and application thereof |
| 04/06/2011 | CN101664452B Drug combination containing musk |
| 04/06/2011 | CN101618176B Chinese medicament for treating dyslipidemia and atherosclerosis |
| 04/06/2011 | CN101618056B Great burdock achene Chinese herb soft capsule preparation and preparation method thereof |
| 04/06/2011 | CN101559121B Sports tonica |
| 04/06/2011 | CN101554426B Traditional Chinese medicine for treating diabetic obstipation |
| 04/06/2011 | CN101550112B 4,5-disubstituted thiazole derivative, preparation method and use thereof |
| 04/06/2011 | CN101538237B Atorvastatin semi-calcium salt butanone co-crystallization substances, preparation and application thereof as HMG-CoA enzyme inhibitor |
| 04/06/2011 | CN101474163B Lovastatin and niacin sustained-release preparation and preparation method thereof |
| 04/06/2011 | CN101474158B Preparation method of vitamin B6 granule for direct tablet forming |
| 04/06/2011 | CN101461800B Application of compound butyl-isobutyl-dimethyl phthalate |
| 04/06/2011 | CN101411786B Diabetic capsule containing trichosanthin, rhizoma coptidis and ginseng |
| 04/06/2011 | CN101396456B Traditional Chinese medicine for treating peripheral nerve lesion of diabetes |
| 04/06/2011 | CN101396454B Traditional Chinese medicine for treating diabetic skin pruritus |
| 04/06/2011 | CN101391092B Chinese patent medicine for curing diabetes and preparation method thereof |
| 04/06/2011 | CN101371875B Method for extracting and preparing total saponin of compound abnormal savda mature agent |
| 04/06/2011 | CN101352487B Long pepper extract, preparation method thereof, medicament composition and uses thereof |
| 04/06/2011 | CN101322778B Double-layer sustained release tablets for compensating iron and preparation thereof |
| 04/06/2011 | CN101311167B 1-phenyl glyoxaline alkane -2,4-dione derivates and uses thereof |
| 04/06/2011 | CN101279096B Pullulan polysaccharide Vc coating combination |
| 04/06/2011 | CN101273999B Jinhuakui products and uses thereof |
| 04/06/2011 | CN101259122B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101259121B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101130491B Oligomer having fatty acid synthase restraining activity and uses thereof |
| 04/06/2011 | CN101095720B Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof |
| 04/06/2011 | CN101062078B Extract of stevia whole stevioside and stevia whole flavone and the preparing method thereof |
| 04/06/2011 | CN101062077B Method for preparing stevia whole stevioside and stevia whole flavone at the same time |
| 04/06/2011 | CN101056861B Carbamoyl-substituted spiro derivative |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919329 Method for screening for agents that affect food intake |
| 04/05/2011 | US7919116 Controlled release metformin formulations |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | US7919080 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2463348C Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 04/05/2011 | CA2436402C Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/31/2011 | WO2011038152A2 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | WO2011038110A2 Methods of treating metabolic disease |
| 03/31/2011 | WO2011038014A2 Composition and method for treatment of diabetes |
| 03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
| 03/31/2011 | WO2011037223A1 Agent for reducing visceral fat weight |
| 03/31/2011 | WO2011036576A1 Gpr 119 modulators |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011035402A1 Active anti-hyperglycaemic and anti-obesity phytotherapeutic compound |
| 03/31/2011 | WO2010141074A3 O-glcnac transferase inhibitors and uses thereof |
| 03/31/2011 | WO2010135429A3 Compositions for modulating a kinase cascade and mehtods of use thereof |
| 03/31/2011 | WO2010132882A3 Sublingual dexmedetomidine compositions and methods of use thereof |
| 03/31/2011 | WO2010132580A3 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| 03/31/2011 | WO2010129524A3 Plant medicinal compounds |
| 03/31/2011 | WO2010127197A3 Method and composition for treating diabetic ketoacidosis |
| 03/31/2011 | WO2010120797A3 Methods of reduction of interpatient variability |
| 03/31/2011 | WO2010118330A3 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 03/31/2011 | WO2010118250A3 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis |
| 03/31/2011 | WO2010118034A3 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells |
| 03/31/2011 | WO2010116141A3 Drug combination for the treatment of proteostatic diseases |
| 03/31/2011 | WO2010093802A3 Therapeutic method for increasing pancreatic beta cell mass |
| 03/31/2011 | US20110077402 Administration of dipeptidyl peptidase inhibitors |
| 03/31/2011 | US20110077303 Increasing glutathione levels for therapy |
| 03/31/2011 | US20110077300 Metabolic Benefits to Butyrate as a Chronic Diet Supplement |
| 03/31/2011 | US20110077299 Inhibitors of alpha4 mediated cell adhesion |
| 03/31/2011 | US20110077295 Andrographolide derivatives and use thereof in manufacture of medicaments |